TD Cowen lowered the firm’s price target on Avantor (AVTR) to $28 from $31 and keeps a Buy rating on the shares. The firm said Q3 was better than expected save for the significant weakness in Semis. Bioprocess looked good, Lab saw modest improvement with strong cost out and FCF.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR: